Allena Pharmaceuticals In... (ALNA)

NASDAQ: ALNA · Real-Time Price · USD

0.07

-0.00 (-3.71%)

At close: Sep 07, 2022, 8:00 PM

Allena Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q4 2016
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Dec 31, 2016
Cash & Equivalents	6.59M	8.89M	29.99M	40.42M	26.66M	36.29M	35.04M	30.14M	26.45M	20.45M	30.01M	39.42M	48.52M	51.76M	61.64M	70.56M	78.85M	86.38M	94.49M	33.87M	34.71M	25.25M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.25M	23.5M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	123K	123K	123K	128K	173K	123K	123K	173K	123K	123K	123K	123K	123K	390K	246K	191K	96K	96K	89K	1.68M	114K	35K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	9.9M	11.3M	3.02M	1.53M	1.67M	2.22M	2.21M	1.18M	1.92M	2.32M	3.03M	2.16M	3.73M	1.32M	2.83M	2.18M	911K	962K	1.54M	577K	350K	520K
Total Current Assets	16.49M	20.2M	33.01M	41.95M	28.32M	38.51M	37.25M	31.32M	28.38M	22.77M	33.03M	41.58M	52.25M	53.07M	64.47M	72.74M	79.76M	87.34M	96.03M	34.45M	38.31M	49.27M
Property-Plant & Equipment	1.2M	1.41M	1.63M	1.79M	1.79M	1.84M	1.56M	477K	609K	781K	950K	1.06M	1.21M	1.35M	514K	469K	204K	128K	127K	134K	153K	169K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.32M	1.53M	1.75M	1.92M	1.96M	1.96M	1.68M	650K	732K	904K	1.07M	1.19M	1.33M	1.74M	760K	660K	300K	224K	216K	1.81M	267K	204K
Total Assets	17.81M	21.73M	34.76M	43.87M	30.29M	40.47M	38.93M	31.97M	29.11M	23.67M	34.11M	42.77M	53.58M	54.81M	65.23M	73.4M	80.06M	87.57M	96.25M	36.26M	38.58M	49.48M
Account Payables	2.27M	3.08M	1.03M	3.03M	2.52M	2.88M	2.41M	1.21M	570K	1.74M	3.05M	3.6M	2.28M	2.6M	2.14M	1.78M	899K	2.15M	1.72M	1.91M	1.24M	1.46M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	380K	5.35M	317K	300K	300K	252K	291K	166K	4.29M	4.42M	4.49M	3.52M	2.51M	1.5M	n/a	n/a	n/a	3.87M	3.87M	3.07M	2.09M	176K
Other Current Liabilities	7.77M	1.69M	14.33M	4.35M	4.98M	3.62M	3.42M	2.54M	1.89M	1.86M	3.37M	3.37M	2.89M	2.67M	3.63M	3.16M	1.83M	1.22M	1.95M	2.16M	846K	1.61M
Total Current Liabilities	10.43M	10.12M	15.68M	7.67M	7.8M	6.75M	6.12M	3.92M	6.74M	8.02M	10.91M	10.49M	7.68M	6.78M	5.76M	4.94M	2.73M	7.25M	7.54M	7.14M	4.17M	3.25M
Long-Term Debt	380K	n/a	210K	10.17M	10.22M	10.22M	9.85M	9.87M	3.99M	4.99M	5.99M	6.99M	7.98M	8.98M	9.98M	9.98M	9.98M	4.54M	5.52M	6.62M	7.55M	9.41M
Other Long-Term Liabilities	3.27M	n/a	n/a	n/a	n/a	n/a	387K	n/a	n/a	n/a	14K	102K	241K	377K	30K	37K	6K	377K	320K	96.5M	210K	96.1M
Total Long-Term Liabilities	3.65M	8.43M	210K	10.17M	10.22M	10.22M	10.24M	9.87M	3.99M	4.99M	6M	7.09M	8.22M	9.36M	10.01M	10.01M	9.98M	4.91M	5.84M	103.13M	7.76M	105.51M
Total Liabilities	14.07M	10.12M	15.89M	17.84M	18.02M	16.97M	16.36M	13.79M	10.73M	13.01M	16.91M	17.58M	15.91M	16.13M	15.77M	14.95M	12.71M	12.16M	13.38M	110.26M	11.93M	108.76M
Total Debt	380K	5.35M	527K	10.47M	10.52M	10.47M	10.14M	10.04M	8.28M	9.41M	10.48M	10.51M	10.5M	10.49M	9.98M	9.98M	9.98M	8.41M	9.39M	9.69M	9.64M	9.59M
Common Stock	108K	90K	83K	80K	59K	57K	51K	38K	32K	25K	25K	23K	23K	21K	21K	21K	21K	20K	20K	1K	15K	1K
Retained Earnings	-266.7M	-258.26M	-246.45M	-236.09M	-223.4M	-209.43M	-197.79M	-187.53M	-179.5M	-172.53M	-164.94M	-153.59M	-140.3M	-129.02M	-117.61M	-107.99M	-98.48M	-89.84M	-81.96M	-75.28M	-70.61M	-60.31M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-423K	n/a	n/a	n/a	-259K	n/a	n/a	n/a	n/a	-17.97M	n/a	-2K
Shareholders Equity	3.74M	11.62M	18.87M	26.03M	12.27M	23.5M	22.57M	18.18M	18.37M	10.66M	17.2M	25.19M	37.67M	38.68M	49.46M	58.45M	67.35M	75.41M	82.87M	-74M	26.65M	-59.28M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.25M	23.5M

Advertisement

Allena Pharmaceuticals In... (ALNA)

Allena Pharmaceuticals Balance Sheet Statement